March 3, 2026Open Access

In Vitro Metabolism and Analytical Characterization of SLU‐PP‐332 and SLU‐PP‐915: Novel Pan‐ERR Agonists With Doping Potential

Key Points

Analysis reveals the metabolic pathways for SLU-PP-332 and SLU-PP-915, both pan-ERR agonists with potential doping applications.
The study highlights that these new compounds could be misused for enhancing athletic performance, raising ethical concerns.
Metabolism studies provide critical insights into how rapidly the compounds are processed in vitro, potentially influencing their effects.
Identifying the characteristics of these substances may inform guidelines to combat their misuse in sports and athletics.

Abstract

The results obtained in this study gave an in-depth view into the analysis and in vitro metabolism of the newly developed pan-ERR agonists SLU-PP-332 and SLU-PP-915. This may help to uncover the illicit use of these novel compounds as potential performance-enhancing substances.

In Vitro Metabolism and Analytical Characterization of SLU‐PP‐332 and SLU‐PP‐915: Novel Pan‐ERR Agonists With Doping Potential

Key Points

Abstract

Cite This Study

Also Consider

Also Consider